[1]
|
Kang, M., Xin, H., Yuan, J., et al. (2021) Transmission Dynamics and Epidemiological Characteristics of SARS- CoV-2 Delta Variant Infections in Guangdong, China, May to June 2021. Eurosurveilance, 27, Article ID: 2100815.
https://doi.org/10.2807/1560-7917.ES.2022.27.10.2100815
|
[2]
|
Singh, J., Rahman, S.A., Ehtesham, N.Z., Hira, S. and Hasnain, S.E. (2021) SARS-CoV-2 Variants of Concern Are Emerging in India. Nature Medicine, 27, 1131-1133. https://doi.org/10.1038/s41591-021-01397-4
|
[3]
|
Tian, D., Sun, Y., Zhou, J. and Ye, Q. (2021) The Global Epi-demic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape. Frontiers in Immunology, 12, Arti-cle 751778. https://doi.org/10.3389/fimmu.2021.751778
|
[4]
|
Nunes-Vaz, R. and Macintyre, C.R. (2021) Rapid Reports and Perspectives from the Field: Observations on the Current Outbreak of the SARS-CoV-2 Delta Variant in Sydney. Global Biosecurity, 3. https://doi.org/10.31646/gbio.121
|
[5]
|
Dhar, M.S., Marwal, R., Vs, R., et al. (2021) Genomic Characterization and Epidemiology of an Emerging SARS-CoV-2 variant in Delhi, India. Science, 374, 995-999. https://doi.org/10.1126/science.abj9932
|
[6]
|
Yaniv, K., Ozer, E., Shagan, M., et al. (2022) Managing an Evolving Pandemic: Cryptic Circulation of the Delta Variant during the Omicron Rise. Science of the Total Environment, 836, Arti-cle ID: 155599.
https://doi.org/10.1016/j.scitotenv.2022.155599
|
[7]
|
Menni, C., Valdes, A.M., Polidori, L., et al. (2022) Symptom Prevalence, Duration, and Risk of Hospital Admission in Individuals Infected with SARS-CoV-2 during Periods of Omicron and Delta Variant Dominance: A Prospective Observational Study From the ZOE COVID Study. The Lancet, 399, 1618-1624.
https://doi.org/10.1016/S0140-6736(22)00327-0
|
[8]
|
Fiolet, T., Kherabi, Y., Macdonald, C.J., Ghosn, J. and Peiffer-Smadja, N. (2022) Comparing COVID-19 Vaccines for Their Characteristics, Efficacy and Effectiveness against SARS-CoV-2 and Variants of Concern: A Narrative Review. Clinical Microbiology and Infection, 28, 202-221. https://doi.org/10.1016/j.cmi.2021.10.005
|
[9]
|
Gupta, N., Kaur, H., Yadav, P.D., et al. (2021) Clinical Characteri-zation and Genomic Analysis of Samples from COVID- 19 Breakthrough Infections during the Second Wave among the Various States of India. Viruses, 13, Article No. 1782.
https://doi.org/10.3390/v13091782
|
[10]
|
Dougherty, K., Mannell, M., Naqvi, O., Matson, D. and Stone, J. (2021) SARS-CoV-2 B.1.617.2 (Delta) Variant COVID- 19 Outbreak Associated with a Gymnastics Facility—Oklahoma, April-May 2021. Morbidity and Mortality Weekly Report, 70, 1004-1007. https://doi.org/10.15585/mmwr.mm7028e2
|
[11]
|
Xu, J. and Zhang, Y. (2020) Traditional Chinese Medicine Treat-ment of COVID-19. Complementary Therapies in Clinical Practice, 39, Article ID: 101165. https://doi.org/10.1016/j.ctcp.2020.101165
|
[12]
|
Qi, H.-X., Shen, Q.-D., Zhao, H.-Y., Qi, G.-Z. and Gao, L. (2022) Network-Based Analysis Revealed Significant Interactions between Risk Genes of Severe COVID-19 and Host Genes Interacted with SARS-CoV-2 Proteins. Briefings in Bioinformatics, 23, Article No. bbab372. https://doi.org/10.1093/bib/bbab372
|
[13]
|
Zhang, Y.-Q., Mao, X., Guo, Q.-Y., Lin, N. and Li, S. (2016) Network Pharmacology-Based Approaches Capture Essence of Chinese Herbal Medicines. Chinese Herbal Medicines, 8, 107-116.
https://doi.org/10.1016/S1674-6384(16)60018-7
|
[14]
|
Xu, Z., Shi, L., Wang, Y., et al. (2020) Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome. The Lancet Respiratory Medicine, 8, 420-422. https://doi.org/10.1016/S2213-2600(20)30076-X
|
[15]
|
Chen, N., Zhou, M., Dong, X., et al. (2020) Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. Lancet, 395, 507-513.
https://doi.org/10.1016/S0140-6736(20)30211-7
|
[16]
|
Huang, H., Zhang, M., Chen, C., et al. 2020() Clinical Char-acteristics of COVID-19 in Patients with Preexisting ILD: A Retrospective Study in a Single Center in Wuhan, China. Journal of Medical Virology, 92, 2742-1750.
https://doi.org/10.1002/jmv.26174
|
[17]
|
Cheng, L., Wang, F., Zhang, S.B. and You, Q.Y. (2021) Network Phar-macology Integrated Molecular Docking Reveals the Anti-COVID-19 and SARS Mechanism of Fufang Banlangen Keli. Natural Product Communications, 16.
https://doi.org/10.1177/1934578X20988420
|
[18]
|
Harrison, A.G., Lin, T. and Wang, P. (2020) Mechanisms of SARS-CoV-2 Transmission and Pathogenesis. Trends in Immunology, 41, 1100-1115. https://doi.org/10.1016/j.it.2020.10.004
|
[19]
|
Evans, J.P., Qu, P., Zeng, C., et al. (2022) Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants. New England Journal of Medicine, 386, 2340-2342. https://doi.org/10.1056/NEJMc2205019
|
[20]
|
Zhang, H., Penninger, J.M., Li, Y., Zhong, N. and Slutsky, A.S. (2020) Angiotensin-Converting Enzyme 2 (ACE2) as a SARS-CoV-2 Receptor: Molecular Mechanisms and Potential Therapeutic Target. Intensive Care Medicine, 46, 586- 590. https://doi.org/10.1007/s00134-020-05985-9
|
[21]
|
Drayman, N., Demarco, J.K., Jones, K.A., et al. (2021) Masitinib Is a Broad Coronavirus 3CL Inhibitor That Blocks Replication of SARS-CoV-2. Science, 373, 931-936. https://doi.org/10.1126/science.abg5827
|
[22]
|
Ruan, X., Du, P., Zhao, K., et al. (2020) Mechanism of Dayuanyin in the Treatment of Coronavirus Disease 2019 Based on Network Pharmacology and Molecular Docking. Chinese Medicine, 15, Article No. 62.
https://doi.org/10.1186/s13020-020-00346-6
|
[23]
|
Maurya, V.K., Kumar, S., Bhatt, M.L. and Saxena, S.K. (2022) A Antiviral Activity of Traditional Medicinal Plants from Ayurveda against SARS-CoV-2 Infection. Journal of Bio-molecular Structure and Dynamics, 40, 1719-1735.
https://doi.org/10.1080/07391102.2020.1832577
|
[24]
|
Sarkar, A., Agarwal, R. and Bandyopadhyay, B. (2022) Molecular Docking Studies of Phytochemicals from Terminalia chebula for Identification of Potential Multi-Target In-hibitors of SARS-CoV-2 Proteins. Journal of Ayurveda and Integrative Medicine, 13, Article ID: 100557. https://doi.org/10.1016/j.jaim.2022.100557
|
[25]
|
Furusawa, J.-I., Funakoshi-Tago, M., Mashino, T., et al. (2009) Glycyrrhiza inflata-Derived Chalcones, Licochalcone A, Licochalcone B and Licochalcone D, Inhibit Phosphorylation of NF-κB P65 in LPS Signaling Pathway. International Immunopharmacology, 9, 499-507. https://doi.org/10.1016/j.intimp.2009.01.031
|
[26]
|
Kar, P., Sharma, N. R., Singh, B., Sen, A. and Roy, A. (2021) Natural Compounds from Clerodendrum Spp. as Possible Therapeutic Candidates against SARS-CoV-2: An in Silico Investigation. Journal of Biomolecular Structure and Dynamics, 39, 4774-4785. https://doi.org/10.1080/07391102.2020.1780947
|
[27]
|
Ping, F., Wang, Y., Shen, X., et al. (2022) Virtual Screening and Molecular Docking to Study the Mechanism of Chinese Medicines in the Treatment of Coronavirus Infection. Medi-cal Science Monitor, 28, e934102.
https://doi.org/10.12659/MSM.934102
|
[28]
|
Wang, Y., Yang, R., Yan, F., et al. (2022) Medicarpin Protects Cere-bral Microvascular Endothelial Cells against Oxygen-Glucose Deprivation/Reoxygenation-Induced Injury via the PI3K/Akt/FoxO Pathway: A Study of Network Pharmacology Analysis and Experimental Validation. Neurochemical Research, 47, 347-357.
https://doi.org/10.1007/s11064-021-03449-0
|
[29]
|
Zhan, Y., Ta, W., Tang, W., et al. (2021) Potential Antiviral Ac-tivity of Isorhamnetin against SARS-CoV-2 Spike Pseudotyped Virus in Vitro. Drug Development Research, 82, 1124-1130. https://doi.org/10.1002/ddr.21815
|
[30]
|
Boesch-Saadatmandi, C., Loboda, A., Wagner, A.E., et al. (2011) Effect of Quercetin and Its Metabolites Isorhamnetin and Quercetin-3-Glucuronide on Inflammatory Gene Ex-pression: Role of miR-155. The Journal of Nutritional Biochemistry, 22, 293-299. https://doi.org/10.1016/j.jnutbio.2010.02.008
|
[31]
|
Khan, N.M., Haseeb, A., Ansari, M.Y., et al. (2017) Wogonin, a Plant Derived Small Molecule, Exerts Potent Anti-Inflammatory and Chondroprotective Effects Through the Activation of ROS/ERK/Nrf2 Signaling Pathways in Human Osteoarthritis Chondrocytes. Free Radical Biology and Medicine, 106, 288-301.
https://doi.org/10.1016/j.freeradbiomed.2017.02.041
|
[32]
|
Yeh, C.-H., Shih, H.-C., Hong, H.-M., et al. (2015) Protective Effect of Wogonin on Proinflammatory Cytokine Generation via Jak1/3-STAT1/3 Pathway in Lipopolysaccha-ride Stimulated BV2 Microglial Cells. Toxicology and Industrial Health, 31, 960-966. https://doi.org/10.1177/0748233713485886
|
[33]
|
Zhao, L., Sha, Y.-Y., Zhao, Q., et al. (2013) Enhanced 5-Fluorouracil Cytotoxicity in High COX-2 Expressing Hepatocellular Carcinoma Cells by Wogonin via the PI3K/Akt Pathway. Biochemistry and Cell Biology, 91, 221-229.
https://doi.org/10.1139/bcb-2012-0077
|
[34]
|
Wang, H., Zhao, L., Zhu, L.-T., et al. (2014) Wogonin Reverses Hy-poxia Resistance of Human Colon Cancer HCT116 Cells via Downregulation of HIF-1α and Glycolysis, by Inhibiting PI3K/Akt Signaling Pathway. Molecular Carcinogenesis, 53, E107-E118. https://doi.org/10.1002/mc.22052
|
[35]
|
Thiyagarajan, P., Chandrasekaran, C.V., Deepak, H.B. and Agarwal, A. (2011) Modulation of Lipopolysaccharide-Induced Pro-Inflammatory Mediators by an Extract of Glycyrrhiza glabra and Its Phytoconstituents. Inflammopharmacology, 19, 235-241. https://doi.org/10.1007/s10787-011-0080-x
|
[36]
|
Liu, W., Zheng, W., Cheng, L., et al. (2022) Citrus Fruits Are Rich in Flavonoids for Immunoregulation and Potential Tar-geting ACE2. Natural Products and Bioprospecting, 12, Article No. 4. https://doi.org/10.1007/s13659-022-00325-4
|
[37]
|
Li, H.-L., Zhou, J.-P. and Deng, J.-M. (2022) Therapeutic Mechanism of Xiaoqinglong Decoction against COVID-19 Based on Network Pharmacology and Molecular Docking Technology. Combinatorial Chemistry & High Throughput Screening, 25, 2264-2277. https://doi.org/10.2174/1386207325666220228154231
|
[38]
|
Gallo, C.G., Fiorino, S., Posabella, G., et al. (2022) The Function of Specialized Pro-Resolving Endogenous Lipid Mediators, Vitamins, and Other Micronutrients in the Control of the Inflammatory Processes: Possible Role in Patients with SARS-CoV-2 Related Infection. Prostaglandins & Other Lipid Mediators, 159, Article ID: 106619.
https://doi.org/10.1016/j.prostaglandins.2022.106619
|
[39]
|
Yi, L., Li, Z., Yuan, K., et al. (2004) Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells. Journal of Virology, 78, 11334-11339. https://doi.org/10.1128/JVI.78.20.11334-11339.2004
|
[40]
|
Shahbazi, B., Mafakher, L. and Teimoori-Toolabi, L. (2022) Different Compounds against Angiotensin-Converting Enzyme 2 (ACE2) Receptor Poten-tially Containing the Infectivity of SARS-CoV-2: An in Silico Study. Journal of Molecular Modeling, 28, Article No. 82. https://doi.org/10.1007/s00894-022-05059-1
|
[41]
|
Ren, J., Lu, Y., Qian, Y., et al. (2019) Recent Progress Regard-ing Kaempferol for the Treatment of Various Diseases (Review). Experimental and Therapeutic Medicine, 18, 2759-2776. https://doi.org/10.3892/etm.2019.7886
|
[42]
|
Ngwe Tun, M.M., Toume, K., Luvai, E., et al. (2022) The Discovery of Herbal Drugs and Natural Compounds as Inhibitors of SARS-CoV-2 Infection in Vitro. Journal of Natural Medicines, 76, 402-409.
https://doi.org/10.1007/s11418-021-01596-w
|
[43]
|
Patel, S.K.S., Lee, J.-K. and Kalia, V.C. (2020) Deploying Bi-omolecules as Anti-COVID-19 Agents. Indian Journal of Microbiology, 60, 263-268. https://doi.org/10.1007/s12088-020-00893-4
|
[44]
|
Goc, A., Niedzwiecki, A., Ivanov, V., Ivanova, S. and Rath, M. (2022) Inhibitory Effects of Specific Combination of Natural Compounds against SARS-CoV-2 and Its Alpha, Beta, Gamma, Delta, Kappa, and Mu Variants. European Journal of Microbiology and Immunology, 11, 87-94. https://doi.org/10.1556/1886.2021.00022
|
[45]
|
Huang, K., Zhang, P., Zhang, Z., et al. (2021) Traditional Chinese Medicine (TCM) in the Treatment of COVID-19 and Other Viral Infections: Efficacies and Mechanisms. Pharmacology & Therapeutics, 225, Article ID: 107843.
https://doi.org/10.1016/j.pharmthera.2021.107843
|
[46]
|
Liu, Z., Li, X., Gou, C., et al. (2020) Effect of Jinhua Qinggan Granules on Novel Coronavirus Pneumonia in Patients. Journal of Traditional Chinese Medicine, 40, 467-472.
|
[47]
|
Mermod, N., Williams, T. and Tjian, R. (1988) Enhancer Binding Factors AP-4 and AP-1 Act in Concert to Activate SV40 Late Transcription in Vitro. Nature, 332, 557-561. https://doi.org/10.1038/332557a0
|
[48]
|
Wang, B., Chen, J., Santiago, F.S., et al. (2010) Phosphorylation and Acetylation of Histone H3 and Autoregulation by Early Growth Response 1 Mediate Interleukin 1β Induction of Early Growth Response 1 Transcription. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 536-545. https://doi.org/10.1161/ATVBAHA.109.193821
|
[49]
|
Wu, J., Han, Y., Zou, X., et al. (2019) Silica Nanoparticles as an Enhancer in the IL-1β-Induced Inflammation Cycle of A549 Cells. Immunopharmacology and Immunotoxicology, 41, 199-206.
https://doi.org/10.1080/08923973.2019.1569046
|
[50]
|
Yamamoto, T., Sekine, Y., Kashima, K., et al. (2002) The Nuclear Isoform of Protein-Tyrosine Phosphatase Tc-Ptp Regulates Interleukin-6-Mediated Signaling Pathway through STAT3 Dephosphorylation. Biochemical and Biophysical Research Communications, 297, 811-817. https://doi.org/10.1016/S0006-291X(02)02291-X
|
[51]
|
Ma, L., Huang, C., Wang, X.-J., et al. (2017) Lysyl Oxi-dase 3 Is a Dual-Specificity Enzyme Involved in STAT3 Deacetylation and Deacetylimination Modulation. Molecular Cell, 65, 296-309.
https://doi.org/10.1016/j.molcel.2016.12.002
|
[52]
|
Marui, N., Medford, R.M. and Ahmad, M. (2005) Activation of RelA Homodimers by Tumour Necrosis Factor α: A Possible Transcriptional Activator in Human Vascular Endothelial Cells. Biochemical Journal, 390, 317-324.
https://doi.org/10.1042/BJ20041659
|